3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Docetaxel
7
Radiotherapy
6
Filgrastim
6
Cisplatin
4
Peripheral Blood Stem Cell Transplantation
3
Chemotherapy, Adjuvant
3
Carboplatin
3
selpercatinib
2
sargramostim
2
Thiotepa
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Gemcitabine
2
Etoposide
2
Drug Therapy
2
Doxorubicin
2
Capecitabine
2
Biopsy
2
Acupuncture Therapy
2
vocimagene amiretrorepvec
1
vandetanib
1
ulixertinib
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tanespimycin
1
spartalizumab
1
pentetreotide
1
pazopanib
1
oncogene protein E7, Human papillomavirus type 16
1
oblimersen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Patient-Specific Modeling
×
CNS
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn